Romeo · Antioxidants (Basel, Switzerland) 2024 · In vitro cell culture and in vivo animal study · n=?

Multiple Mechanisms of Action of Sulfodyne ® , a Natural Antioxidant, against Pathogenic Effects of SARS-CoV-2 Infection.

Cited 2 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Preclinical in vitro cell culture and transgenic animal research

PubMed 39334742 · doi:10.3390/antiox13091083 · record verified 2026-08-30

What was done

Researchers tested Sulfodyne (a stabilized formulation of natural sulforaphane) against SARS-CoV-2 infection across cellular models (pulmonary and colonic epithelial cell lines, bystander human monocytes) and an in vivo animal model (K18-hACE2 transgenic mice). They evaluated viral replication compared to other NRF2-agonists (DMF and CDDO), assessed cellular stress pathways (ER stress, mTOR signaling), measured inflammatory markers (IFNB1, type I interferon-stimulated genes, monocyte activation), and evaluated lung viral load and disease severity in infected mice.

What was found

In pulmonary and colonic epithelial cell lines, Sulfodyne inhibited SARS-CoV-2 replication more efficiently than DMF and CDDO through an NRF2-independent mechanism associated with the inhibition of ER stress and mTOR signaling. Sulfodyne reduced inflammatory responses by suppressing the delayed induction of IFNB1 and type I interferon-stimulated genes in epithelial cells and decreasing activation in bystander human monocytes. In SARS-CoV-2-infected K18-hACE2 mice, Sulfodyne reduced early lung viral load and disease severity. The abstract reports no specific numerical data, effect sizes, or confidence intervals.

Why it matters

The study identifies multiple preclinical mechanisms through which stabilized sulforaphane exerts antiviral and immunomodulatory activity against SARS-CoV-2.

Limits

This is strictly a preclinical investigation relying on immortalized cell lines and transgenic mice; efficacy, optimal dosing, and safety cannot be inferred for human clinical COVID-19. The abstract omits sample sizes (number of mice or assay replicates), exact dosages, quantitative effect sizes, and statistical measures.

Cited by